Literature DB >> 12071107

Fatal case of inhalational anthrax mimicking intra-abdominal sepsis.

Richard Quintiliani1, Richard Quintiliani1.   

Abstract

In this report, we discuss the second fatal case of inhalational anthrax related to the use of Bacillus anthracis spores as a biological weapon in the United States. This case highlights two of the major characteristics of inhalational anthrax: the fulminating nature of the infection and the difficulty of promptly establishing a diagnosis. In the patient discussed here, gastrointestinal symptoms and findings were so impressive that the patient was thought to have a primary intra-abdominal condition. In the current situation, in which bioterrorism is a real threat, any patient presenting with a flulike or gastrointestinal illness should be queried about their occupation. Anyone with evidence of systemic disease who resides or works in a geographical region where anthrax cases are occurring should be treated until the diagnosis of anthrax is excluded. In the United States, the group that is at high risk for anthrax has shifted from rural farm workers to city dwellers, especially postal workers and public figures.

Entities:  

Mesh:

Year:  2002        PMID: 12071107

Source DB:  PubMed          Journal:  Conn Med        ISSN: 0010-6178


  6 in total

Review 1.  Antimicrobial Treatment for Systemic Anthrax: Analysis of Cases from 1945 to 2014 Identified Through a Systematic Literature Review.

Authors:  Satish K Pillai; Eileen Huang; Julie T Guarnizo; Jamechia D Hoyle; Stefan Katharios-Lanwermeyer; Theresa K Turski; William A Bower; Katherine A Hendricks; Dana Meaney-Delman
Journal:  Health Secur       Date:  2015-12-01

2.  Postexposure prophylaxis against anthrax: evaluation of various treatment regimens in intranasally infected guinea pigs.

Authors:  Zeev Altboum; Yehoshua Gozes; Ada Barnea; Avi Pass; Moshe White; David Kobiler
Journal:  Infect Immun       Date:  2002-11       Impact factor: 3.441

3.  Pathology and pathogenesis of bioterrorism-related inhalational anthrax.

Authors:  Jeannette Guarner; John A Jernigan; Wun-Ju Shieh; Kathleen Tatti; Lisa M Flannagan; David S Stephens; Tanja Popovic; David A Ashford; Bradley A Perkins; Sherif R Zaki
Journal:  Am J Pathol       Date:  2003-08       Impact factor: 4.307

4.  Characterization of anthrolysin O, the Bacillus anthracis cholesterol-dependent cytolysin.

Authors:  Jeffrey G Shannon; Cana L Ross; Theresa M Koehler; Richard F Rest
Journal:  Infect Immun       Date:  2003-06       Impact factor: 3.441

5.  Nonhemolytic, nonmotile gram-positive rods indicative of Bacillus anthracis.

Authors:  Elie G Dib; Samar A Dib; Dany A Korkmaz; Neville K Mobarakai; Jordan B Glaser
Journal:  Emerg Infect Dis       Date:  2003-08       Impact factor: 6.883

Review 6.  Does Bacillus anthracis Lethal Toxin Directly Depress Myocardial Function? A Review of Clinical Cases and Preclinical Studies.

Authors:  Dante A Suffredini; Hanish Sampath-Kumar; Yan Li; Lernik Ohanjanian; Kenneth E Remy; Xizhong Cui; Peter Q Eichacker
Journal:  Toxins (Basel)       Date:  2015-12-12       Impact factor: 4.546

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.